Introducing the EMERALD Trial | Managed Healthcare Executive
Introducing the EMERALD Trial | Managed Healthcare Executive
2 months ago
managedhealthcareexecutive.com
Efficacy Outcomes from PHAROS | Managed Healthcare Executive
Efficacy Outcomes from PHAROS | Managed Healthcare Executive
1 month ago
managedhealthcareexecutive.com
The Future of CKD Screening | Managed Healthcare Executive
The Future of CKD Screening | Managed Healthcare Executive
1 month ago
managedhealthcareexecutive.com
Analyzing Pain and Fatigue Outcomes | Managed Healthcare Executive
Analyzing Pain and Fatigue Outcomes | Managed Healthcare E…
3 months ago
managedhealthcareexecutive.com
Future Management Options for Vitiligo | Managed Healthcare Executive
Future Management Options for Vitiligo | Managed Healthcare Exe…
3 months ago
managedhealthcareexecutive.com
Exploring the Stages of CKD | Managed Healthcare Executive
Exploring the Stages of CKD | Managed Healthcare Executive
1 month ago
managedhealthcareexecutive.com
The Movement Towards Modular Health Plans | PBMI 2025 | Managed Healthcare Executive
The Movement Towards Modular Health Plans | PBMI 2025 | Manage…
4 months ago
managedhealthcareexecutive.com
Understanding Keratoconus and Its Early Treatment | AAO 2025 | Man…
2 months ago
managedhealthcareexecutive.com
Tackling Health Inequities Through Collaboration and Community-Bas…
2 months ago
managedhealthcareexecutive.com
Expert Discussion on Safety Results of Guselkumab for Crohn’s Diseas…
2 months ago
managedhealthcareexecutive.com
AI and Virtual Care Are Shaping the Future of Dermatology | Managed …
2 months ago
managedhealthcareexecutive.com
Scripius Saw 86% Net Cost Reduction After Switching to Stela…
3 months ago
managedhealthcareexecutive.com
Exploring Nintedanib and Pirfenidone for the Treatment of Id…
10 months ago
managedhealthcareexecutive.com
In AI vs. Humans, AI Can ‘Surpass’ and By Far | AAO 2025 | Managed …
2 months ago
managedhealthcareexecutive.com
More Innovative Cell and Gene Therapy Payment Strategies Need…
8 months ago
managedhealthcareexecutive.com
Distinguishing Between the Different Interstitial Lung Disease…
Dec 13, 2024
managedhealthcareexecutive.com
Understanding “Delinking” in the PBM Legislation | AMCP 2024 | Ma…
Apr 16, 2024
managedhealthcareexecutive.com
The Advantages of ‘Epi-On’ Over ‘Epi-Off’ Treatment of Keratoconu…
2 months ago
managedhealthcareexecutive.com
The trend toward post-infusion outpatient care of patients treated …
4 weeks ago
managedhealthcareexecutive.com
CAR T-cell treatment numbers may double by 2030 if committee is su…
4 weeks ago
managedhealthcareexecutive.com
Brands of Botulinum Toxin Vary in Potency and Cost But Work the Sa…
2 months ago
managedhealthcareexecutive.com
Will Payers Be an Obstacle to the ‘Epi-On’ Approach to Corneal Coll…
2 months ago
managedhealthcareexecutive.com
Cytokine release syndrome and outpatient care of patients treated …
4 weeks ago
managedhealthcareexecutive.com
Evaluating Biosimilar Interchangeability | Managed Healt…
Sep 6, 2023
managedhealthcareexecutive.com
76% of Autoimmune Patients Receive at Least One Misdiagnosi…
4 months ago
managedhealthcareexecutive.com
Evolving Guidelines: Impact of Gene Therapy and BCG Failure Redefini…
5 months ago
managedhealthcareexecutive.com
Understanding NMIBC and Its Risk Factors | Managed Healthcare Exe…
4 months ago
managedhealthcareexecutive.com
Starting Syfovre Early Helps Protect Vision in Geographic Atrophy | AS…
5 months ago
managedhealthcareexecutive.com
LucyRx CEO David Blair Sees Untapped Potential in Pharmacist…
5 months ago
managedhealthcareexecutive.com
Epidemiology and Economic Burden of IPF and PPF | Managed Healthc…
Dec 27, 2024
managedhealthcareexecutive.com
See more videos
Static thumbnail place holder